Human cytomegalovirus infection and atherothrombosis

Cytomegalovirus: pathogen, paradigm, and puzzle

(2011) Michael Boeckh et al.   JOURNAL OF CLINICAL INVESTIGATION

Maribavir prophylaxis for prevention of cytomegalovirus disease in recipients of allogeneic stem-cell transplants: a phase 3, double-blind, placebo-controlled, randomised trial

(2011) Francisco M Marty et al.   LANCET INFECTIOUS DISEASES

Factors associated with the development of cytomegalovirus infection following solid organ transplantation

(2011) Caspar da Cunha-Bang et al.   SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES

Evaluation and Significance of Cytomegalovirus-Specific Cellular Immune Response in Lung Transplant Recipients

(2011) C. Costa et al.   TRANSPLANTATION PROCEEDINGS

Peptides from cytomegalovirus UL130 and UL131 proteins induce high titer antibodies that block viral entry into mucosal epithelial cells

(2011) Frances M. Saccoccio et al.   VACCINE

In Vitro and In Vivo Activities of the Novel Anticytomegalovirus Compound AIC246

(2010) P. Lischka et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

An International Comparison of Current Strategies to Prevent Herpesvirus and Fungal Infections in Hematopoietic Cell Transplant Recipients

(2010) Margaret Pollack et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Cytomegalovirus Seroprevalence in the United States: The National Health and Nutrition Examination Surveys, 1988–2004

(2010) Sheri Lewis Bate et al.   CLINICAL INFECTIOUS DISEASES

Antiviral Drug Resistance of Human Cytomegalovirus

(2010) N. S. Lurain et al.   CLINICAL MICROBIOLOGY REVIEWS

Infections Transmitted by Transplantation

(2010) Michele I. Morris et al.   INFECTIOUS DISEASE CLINICS OF NORTH AMERICA

Cytomegalovirus Pneumonia: Community-Acquired Pneumonia in Immunocompetent Hosts

(2010) Burke A. Cunha   INFECTIOUS DISEASE CLINICS OF NORTH AMERICA

Cytomegalovirus in Hematopoietic Stem Cell Transplant Recipients

(2010) Per Ljungman et al.   INFECTIOUS DISEASE CLINICS OF NORTH AMERICA

Reconstruction of the complete human cytomegalovirus genome in a BAC reveals RL13 to be a potent inhibitor of replication

(2010) Richard J. Stanton et al.   JOURNAL OF CLINICAL INVESTIGATION

Sequential mutations associated with adaptation of human cytomegalovirus to growth in cell culture

(2010) D. J. Dargan et al.   JOURNAL OF GENERAL VIROLOGY

Human cytomegalovirus increases HUVEC sensitivity to thrombin and modulates expression of thrombin receptors

(2010) Milan Popović et al.   JOURNAL OF THROMBOSIS AND THROMBOLYSIS

Management of cytomegalovirus infection in solid organ transplantation

(2010) Camille N. Kotton   Nature Reviews Nephrology

Incidence of Cytomegalovirus-associated thrombosis and its risk factors: A case-control study

(2010) Lihi Atzmony et al.   THROMBOSIS RESEARCH

Valganciclovir prophylaxis for cytomegalovirus infection in thoracic transplant patients: retrospective study of efficacy, safety, and drug exposure

(2010) S. Lefeuvre et al.   Transplant Infectious Disease

Cytomegalovirus Mismatch as Major Risk Factor for Delayed Graft Function After Pancreas Transplantation

(2010) Manuel Maglione et al.   TRANSPLANTATION

Utility of Leflunomide in the Treatment of Complex Cytomegalovirus Syndromes

(2010) Robin K. Avery et al.   TRANSPLANTATION

Prolonged Prophylaxis With Valganciclovir Is Cost Effective in Reducing Posttransplant Cytomegalovirus Disease Within the United States

(2010) Emily A. Blumberg et al.   TRANSPLANTATION

Neurodevelopmental outcomes following ganciclovir therapy in symptomatic congenital cytomegalovirus infections involving the central nervous system

(2009) Sara E. Oliver et al.   JOURNAL OF CLINICAL VIROLOGY

Development and evidence for efficacy of CMV glycoprotein B vaccine with MF59 adjuvant

(2009) Robert F. Pass   JOURNAL OF CLINICAL VIROLOGY

High-throughput sequence analysis of variants of human cytomegalovirus strains Towne and AD169

(2009) A. J. Bradley et al.   JOURNAL OF GENERAL VIROLOGY

Isolation of Human Monoclonal Antibodies That Potently Neutralize Human Cytomegalovirus Infection by Targeting Different Epitopes on the gH/gL/UL128-131A Complex

(2009) A. Macagno et al.   JOURNAL OF VIROLOGY

Detection of Cytomegalovirus in Atherosclerotic Plaques and Nonatherosclerotic Arteries

(2008) Evangelia Xenaki et al.   ANGIOLOGY

Maribavir prophylaxis for prevention of cytomegalovirus infection in allogeneic stem cell transplant recipients: a multicenter, randomized, double-blind, placebo-controlled, dose-ranging study

(2008) D. J. Winston et al.   BLOOD

Editorial Commentary:Persistent Clinical Impact of Cytomegalovirus in Organ Transplantation

(2008) David R. Snydman   CLINICAL INFECTIOUS DISEASES

Immunoglobulin Prophylaxis in Hematopoietic Stem Cell Transplantation: Systematic Review and Meta-Analysis

(2008) Pia Raanani et al.   JOURNAL OF CLINICAL ONCOLOGY

Human cytomegalovirus serum neutralizing antibodies block virus infection of endothelial/epithelial cells, but not fibroblasts, early during primary infection

(2008) G. Gerna et al.   JOURNAL OF GENERAL VIROLOGY

Registry of the International Society for Heart and Lung Transplantation: Twenty-fifth Official Adult Lung and Heart/Lung Transplantation Report—2008

(2008) Jason D. Christie et al.   JOURNAL OF HEART AND LUNG TRANSPLANTATION

Detection of Human Cytomegalovirus in Atherosclerotic Carotid Arteries in Humans

(2008) Li Yi et al.   JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION

Platelet-derived growth factor-α receptor activation is required for human cytomegalovirus infection

(2008) Liliana Soroceanu et al.   NATURE

Human CMV infection of endothelial cells induces an angiogenic response through viral binding to EGF receptor and  1 and  3 integrins

(2008) G. L. Bentz et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Cytomegalovirus vaccines fail to induce epithelial entry neutralizing antibodies comparable to natural infection

(2008) Xiaohong Cui et al.   VACCINE